Home / team-member / Matthew J. Jennings

Matthew J. Jennings

Operating Partner
  • Investment Status:
  • Mr. Jennings has been affiliated with Kohlberg since 2011 and was named an Operating Partner in 2020.  He is currently Chairman of PCI Pharma Services, Executive Chairman of Cadence and a member of the board of directors of Nelipak Healthcare Packaging and Spinal Elements.  Previously, he served as Chairman, CEO & President of Phillips-Medisize and as a member of the Board of Spectrum Plastics Group and e+CancerCare, all past Kohlberg portfolio companies.  He is responsible for investment thesis development, company diligence and portfolio company operations management in the Medical & Pharmaceutical Products and Services sector.

    Prior to his affiliation with Kohlberg, his senior executive positions included CEO of CoJen Pharma (renamed Covis Pharma); President, North America for Teleflex Incorporated; President & CEO of BioEnterprise; and various senior-level management positions at Cardinal Health, Allegiance Corp., and Baxter International.

    Mr. Jennings received an M.B.A. from Michigan State University’s Eli Broad College of Business and a B.S. from Miami (Ohio) University.